AHK-Cu dosage

AHK-Cu topical dosage

Topical AHK-Cu is applied daily on an ongoing basis. The amount applied depends on the finished product's concentration and formulation.[8]

AHK-Cu acts on dermal-papilla and hair-follicle signaling. Its proposed purpose is follicle support; a dependable human hair-regrowth outcome remains uncertain.[1][2][3][4][8]

AHK-Cu injectable dosage

Reported-use amounts for AHK-Cu are ~250 mcg (market pattern) per administration, daily, for approximately 4 wk.[8]

AHK-Cu acts on dermal-papilla and hair-follicle signaling. Its proposed purpose is follicle support; a dependable human hair-regrowth outcome remains uncertain.[3][4][1][8]

Frequency and timing

Topical use is usually in the evening. Injections are usually timed in the morning.[1][7][8]

Cycle length and breaks

Topical: Ongoing. Injectable: ~4 wk. Ongoing treatment does not follow a routine on/off cycle.[8]

Approval and product quality

AHK-Cu is not an FDA-approved drug.[5][2]

Side effects and long-term safety

Local scalp irritation and product tolerability are the main topical concerns. Human scalp efficacy, topical pharmacokinetics, ideal concentration, long-term scalp safety, pregnancy safety and interactions remain unresolved. Cosmetic tolerability does not establish injectable or disease-treatment safety.[1][2][3][6]

Route-specific dosing limits

Use caution with inflamed scalp, open skin, known cosmetic allergies, pregnancy or breastfeeding, pediatric use, and any injectable or microneedling plan. Reported-use injectable schedules are not established human treatment regimens.[1][2][8]